Aurinia Pharma GAAP EPS of $0.23 beats by $0.07, revenue of $73.47M beats by $5.77M

4 hours ago 1

Aurinia Pharma press release (AUPH): Q3 GAAP EPS of $0.23 beats by $0.07.
Revenue of $73.47M (+8.4% Y/Y) beats by $5.77M.
For 2025, Aurinia is increasing total revenue guidance from a range of $260 million to $270 million to a range of $275 million